Brief: TRACON Pharmaceuticals Q4 Net Income USD 439 Thousand
05/03/2024 21:02
Mar 05 (Reuters) - TRACON Pharmaceuticals Q4 income from operations USD 407 thousand. * Q4 operating expenses USD 2.638 million * Q4 basic EPS USD 0.01
Recent news on TRACON Pharmaceuticals
See all newsBrief: TRACON Pharmaceuticals Says ENVASARC Trial ORR Is 5%, Does Not Meet 11% Endpoint
Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Tracon Pharmaceuticals Inc Expected To Post A Loss Of $1.19 A Share: Earnings Preview
Brief: Tracon Pharmaceuticals Files For Offering Of Common Stock, Pre-Funded Warrants